New York Daily Ledger
SEE OTHER BRANDS

The latest news from New York

New York Daily Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New York Daily Ledger.

Press releases published on April 26, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Manhattan Associates

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Manhattan Associates

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of e.l.f. Beauty

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of e.l.f. Beauty

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Lab USA

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Lab USA

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Everus

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Everus

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BigBear.ai

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BigBear.ai

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AppLovin

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AppLovin

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Perpetua Resources Corp.

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Perpetua Resources Corp.

Faruqi …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bakkt Holdings

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bakkt Holdings

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ultra Clean

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ultra Clean

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skyworks

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skyworks

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fluence Energy

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fluence Energy

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Solaris Energy

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Solaris Energy

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of enCore

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of enCore

Faruqi …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron

Faruqi …

Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC

Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC

TARA-002 demonstrates 100% complete response rate at any time and 67% 12-month landmark complete response rate in BCG-Unresponsive patients TARA-002 demonstrates 76% complete response rate at any time and 43% 12-month landmark complete response rate in BCG …

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SoundHound AI

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SoundHound AI

Faruqi …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service